New Brain Cell Discovery Offers Hope for Alzheimer’s Treatment

Researchers have identified a crucial role for tanycytes, a specialized type of brain cell, in the development of Alzheimer’s disease. This discovery, stemming from a collaborative study by the French National Institute of Health and Medical Research (Inserm), the University of Lille and Lille University Hospital, could pave the way for novel therapeutic strategies targeting the disease’s progression.

Understanding Alzheimer’s Disease

Alzheimer’s disease is a progressive neurodegenerative disorder characterized by cognitive decline, impacting memory, thinking, and spatial orientation [1]. The disease begins with the deterioration of neurons in the hippocampus, the brain region vital for memory, and gradually spreads throughout the brain [1]. Currently, it affects around 900,000 people in France [1].

The Role of Tau Protein

A key hallmark of Alzheimer’s disease is the abnormal accumulation of the Tau protein within neurons [1]. In a healthy brain, Tau protein helps stabilize the internal structure of neurons and is secreted into the cerebrospinal fluid, then eliminated into the bloodstream. However, in Alzheimer’s patients, the structure of Tau changes, preventing it from functioning normally and leading to its pathological accumulation, disrupting brain function [1].

Introducing Tanycytes: A New Piece of the Puzzle

The recent study highlights the involvement of tanycytes, cells located near the brain’s ventricles that regulate the exchange between blood and cerebrospinal fluid [1]. Researchers, led by scientist Vincent Prévot, have been studying these cells for over two decades, previously recognizing their role in transporting hormones like leptin, which regulates appetite and energy balance.

How Tanycytes Impact Tau Protein Transport

The research demonstrates that tanycytes actively transport Tau protein from the brain to the bloodstream [1]. Experiments involving animal models showed that tanycytes capture Tau protein from the cerebrospinal fluid and transport it along their extensions to capillaries, where it is released into the bloodstream. When tanycytic cells were inactivated using a genetic modification, Tau protein transfer was halted, leading to its accumulation in the brain and earlier onset of dementia-like symptoms.

Findings in Human Brains

Further analysis of brain tissue from individuals who died from Alzheimer’s disease revealed the presence of Tau protein within tanycytes and significant damage to these cells [1]. Their cellular extensions were fragmented and disrupted, hindering the normal pathway for protein transport. Notably, this damage was not observed in brains of patients with other forms of dementia, suggesting its specificity to Alzheimer’s disease.

Implications for Future Treatments

This discovery positions tanycytes as a potential therapeutic target for Alzheimer’s disease. Maintaining the health and function of these cells could be crucial in preventing the accumulation of Tau protein and slowing disease progression. Further research is needed to explore strategies for protecting or restoring tanycyte function in Alzheimer’s patients.